RPRX
Royalty Pharma·NASDAQ
--
--(--)
--
--(--)
6.66 / 10
Outperform
Capital flows are robust (7.83/10), with optimistic Small, Medium, and Extra-large inflow patterns, despite a negative overall trend. Analyst coverage is limited but overwhelmingly bullish—100% Strong Buy from Citigroup, with a 100% historical win rate. This positive sentiment partially offsets technical and fundamental weaknesses, contributing to the netural overall rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-27
InstitutionCitigroup
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for RPRX?
- RPRX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.66/10 (Outperform).
